ID

43854

Descripción

Metabolic Effects of Thiazolidinediones in Chronic Kidney Disease; ODM derived from: https://clinicaltrials.gov/show/NCT00368017

Link

https://clinicaltrials.gov/show/NCT00368017

Palabras clave

Versiones (2)
  1. 5/2/17 5/2/17 -
  2. 20/9/21 20/9/21 -
Subido en

20 de septiembre de 2021

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Chronic Kidney Disease NCT00368017

Inglés

Eligibility Chronic Kidney Disease NCT00368017

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. patients with stage 3 or 4 chronic kidney disease as measured by a modification in diet in renal disease study (mdrd) estimate of between 15 ml/min and 59 ml/min.
Descripción

Chronic Kidney Diseases TNM Kidney tumor staging Renal function GFR estimation by MDRD

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1561643
UMLS CUI [1,2]
C0474937
UMLS CUI [1,3]
C2170215
2. age between 18 and 75 years old.
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
3. patients without hospitalization for cardiac or infection related morbidity over the previous four weeks (due to the potential confounding effects on baseline study variables).
Descripción

Morbidity Heart Without Hospitalization | Morbidity Infection Without Hospitalization

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0220880
UMLS CUI [1,2]
C0018787
UMLS CUI [1,3]
C0332288
UMLS CUI [1,4]
C0019993
UMLS CUI [2,1]
C0220880
UMLS CUI [2,2]
C0009450
UMLS CUI [2,3]
C0332288
UMLS CUI [2,4]
C0019993
4. patients who are able to provide consent to participate in the study.
Descripción

Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. patients with prior documented diagnosis of diabetes mellitus.
Descripción

Diabetes Mellitus

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0011849
2. patients with fasting blood glucose > 110mg/dl.
Descripción

Fasting blood glucose measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0428568
3. prisoners, patients will significant mental illness, pregnant women, and other vulnerable populations.
Descripción

Prisoners | Mental disorder Significant | Pregnancy | Vulnerable Populations

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0033167
UMLS CUI [2,1]
C0004936
UMLS CUI [2,2]
C0750502
UMLS CUI [3]
C0032961
UMLS CUI [4]
C0949366
4. patients with active hepatic disease and/or alt > 2.5 times upper limit of normal.
Descripción

Liver diseases | Alanine aminotransferase increased

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023895
UMLS CUI [2]
C0151905
5. patients with history of congestive heart failure and nyha class iii-iv symptoms at any time.
Descripción

Congestive heart failure New York Heart Association Classification

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0018802
UMLS CUI [1,2]
C1275491
6. patients for whom living donor renal transplantation is already scheduled or in the process of being evaluated, as these patients will be unlikely to complete study protocols before transplantation.
Descripción

Kidney Transplantation Living Donors Scheduled | Kidney Transplantation Living Donors Evaluation

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0022671
UMLS CUI [1,2]
C0348050
UMLS CUI [1,3]
C0205539
UMLS CUI [2,1]
C0022671
UMLS CUI [2,2]
C0348050
UMLS CUI [2,3]
C0220825
7. patients with severe co-morbid conditions (eg, symptomatic hepatic cirrhosis, metastatic cancer, hiv infection with aids).
Descripción

Comorbidity Severe | Liver Cirrhosis Symptomatic | Neoplasm Metastasis | hiv-infection/aids

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0205082
UMLS CUI [2,1]
C0023890
UMLS CUI [2,2]
C0231220
UMLS CUI [3]
C0027627
UMLS CUI [4]
C0001175
8. patient with active inflammatory process (eg., sle, rheumatoid arthritis, gout) for which they are currently receiving immune modulating medications.
Descripción

Biological Response Modifiers Inflammatory disorder | Lupus Erythematosus, Systemic | Rheumatoid Arthritis | Gout

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0005525
UMLS CUI [1,2]
C1290884
UMLS CUI [2]
C0024141
UMLS CUI [3]
C0003873
UMLS CUI [4]
C0018099
9. patients who are on corticosteroid therapy.
Descripción

Steroid therapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0149783
10. patients who do not consent to participate in the study.
Descripción

Clinical Trial Refusal to Participate

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0008976
UMLS CUI [1,2]
C1136454
Volver a la parte superior de la página

Similar models

Eligibility Chronic Kidney Disease NCT00368017

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Chronic Kidney Diseases TNM Kidney tumor staging Renal function GFR estimation by MDRD
Item
1. patients with stage 3 or 4 chronic kidney disease as measured by a modification in diet in renal disease study (mdrd) estimate of between 15 ml/min and 59 ml/min.
boolean
C1561643 (UMLS CUI [1,1])
C0474937 (UMLS CUI [1,2])
C2170215 (UMLS CUI [1,3])
Age
Item
2. age between 18 and 75 years old.
boolean
C0001779 (UMLS CUI [1])
Morbidity Heart Without Hospitalization | Morbidity Infection Without Hospitalization
Item
3. patients without hospitalization for cardiac or infection related morbidity over the previous four weeks (due to the potential confounding effects on baseline study variables).
boolean
C0220880 (UMLS CUI [1,1])
C0018787 (UMLS CUI [1,2])
C0332288 (UMLS CUI [1,3])
C0019993 (UMLS CUI [1,4])
C0220880 (UMLS CUI [2,1])
C0009450 (UMLS CUI [2,2])
C0332288 (UMLS CUI [2,3])
C0019993 (UMLS CUI [2,4])
Informed Consent
Item
4. patients who are able to provide consent to participate in the study.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Diabetes Mellitus
Item
1. patients with prior documented diagnosis of diabetes mellitus.
boolean
C0011849 (UMLS CUI [1])
Fasting blood glucose measurement
Item
2. patients with fasting blood glucose > 110mg/dl.
boolean
C0428568 (UMLS CUI [1])
Prisoners | Mental disorder Significant | Pregnancy | Vulnerable Populations
Item
3. prisoners, patients will significant mental illness, pregnant women, and other vulnerable populations.
boolean
C0033167 (UMLS CUI [1])
C0004936 (UMLS CUI [2,1])
C0750502 (UMLS CUI [2,2])
C0032961 (UMLS CUI [3])
C0949366 (UMLS CUI [4])
Liver diseases | Alanine aminotransferase increased
Item
4. patients with active hepatic disease and/or alt > 2.5 times upper limit of normal.
boolean
C0023895 (UMLS CUI [1])
C0151905 (UMLS CUI [2])
Congestive heart failure New York Heart Association Classification
Item
5. patients with history of congestive heart failure and nyha class iii-iv symptoms at any time.
boolean
C0018802 (UMLS CUI [1,1])
C1275491 (UMLS CUI [1,2])
Kidney Transplantation Living Donors Scheduled | Kidney Transplantation Living Donors Evaluation
Item
6. patients for whom living donor renal transplantation is already scheduled or in the process of being evaluated, as these patients will be unlikely to complete study protocols before transplantation.
boolean
C0022671 (UMLS CUI [1,1])
C0348050 (UMLS CUI [1,2])
C0205539 (UMLS CUI [1,3])
C0022671 (UMLS CUI [2,1])
C0348050 (UMLS CUI [2,2])
C0220825 (UMLS CUI [2,3])
Comorbidity Severe | Liver Cirrhosis Symptomatic | Neoplasm Metastasis | hiv-infection/aids
Item
7. patients with severe co-morbid conditions (eg, symptomatic hepatic cirrhosis, metastatic cancer, hiv infection with aids).
boolean
C0009488 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0023890 (UMLS CUI [2,1])
C0231220 (UMLS CUI [2,2])
C0027627 (UMLS CUI [3])
C0001175 (UMLS CUI [4])
Biological Response Modifiers Inflammatory disorder | Lupus Erythematosus, Systemic | Rheumatoid Arthritis | Gout
Item
8. patient with active inflammatory process (eg., sle, rheumatoid arthritis, gout) for which they are currently receiving immune modulating medications.
boolean
C0005525 (UMLS CUI [1,1])
C1290884 (UMLS CUI [1,2])
C0024141 (UMLS CUI [2])
C0003873 (UMLS CUI [3])
C0018099 (UMLS CUI [4])
Steroid therapy
Item
9. patients who are on corticosteroid therapy.
boolean
C0149783 (UMLS CUI [1])
Clinical Trial Refusal to Participate
Item
10. patients who do not consent to participate in the study.
boolean
C0008976 (UMLS CUI [1,1])
C1136454 (UMLS CUI [1,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial